STER-2), the risk of
periprocedural stroke in symptomatic patients from the
two trials combined was 0.6% while mortality risk was
0.6% for a combined risk of stroke and death of
1.2%.177,178 A more recent study comparing TCAR and
transfemoral CAS examined 1829 propensity scorematched patients from the VQI with symptomatic carotid disease. This study demonstrated that